Author： Balfour J.A. Faulds D.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.13, Iss.2, 1998-08, pp. : 173-180
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clinical Pharmacokinetics and Pharmacodynamics of Repaglinide
By Hatorp V.
Clinical Pharmacokinetics, Vol. 41, Iss. 7, 2002-01 ,pp. :
Access to resources
Recommend
Repaglinide improves QOL in diabetes mellitus
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. :
Repaglinide: A Viewpoint by Bruce H.R. Wolffenbuttel
Drugs & Aging, Vol. 13, Iss. 2, 1998-08 ,pp. :
Repaglinide plus an insulin-sensitiser: better glycaemic control
Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. :